Advertisement

Refractory platelet transfusion in a patient with CD36 deficiency due to pseudothrombocytopenia.

14:15 EDT 24th May 2013 | BioPortfolio

Summary of "Refractory platelet transfusion in a patient with CD36 deficiency due to pseudothrombocytopenia."

Type I CD36 deficiency is defined by the absence of CD36 on both platelets and monocytes. Pseudothrombocytopenia (PTCP) is characterized by a false reduction in the number of platelets in ethylenediaminetetraacetic acid (EDTA)-anticoagulated blood. Here we report a rare case of concomitant CD36 deficiency and PTCP. The patient was a 7-year-old boy who suffered comminuted fractures of the left humeral condyle. In the pre-operative examination, he was found to have thrombopenia and assumed to have idiopathic thrombocytopenic purpura. After immunotherapy and platelet transfusion, the platelet count remained low, suggesting that the patient was refractory to platelet transfusion. Serum was collected for the detection of platelet antibodies, and antibodies against CD36 were found. Flow cytometry verified the absence of CD36 on both the platelets and monocytes of this patient. However, the platelet count was normal when capillary blood smears were analysed; in addition, platelet coagulation was noted under the microscope when EDTA-anticoagulated peripheral blood was used. The patient underwent surgery without platelet transfusion and recovered uneventfully.

Affiliation

Department of Hematology, 303rd Hospital of the People's Liberation Army, Nanning, Guangxi, China.

Journal Details

This article was published in the following journal.

Name: Platelets
ISSN: 1369-1635
Pages:

Links

Medical and Biotech [MESH] Definitions

Antigens, Cd36

Leukocyte differentiation antigens and major platelet membrane glycoproteins present on MONOCYTES; ENDOTHELIAL CELLS; PLATELETS; and mammary EPITHELIAL CELLS. They play major roles in CELL ADHESION; SIGNAL TRANSDUCTION; and regulation of angiogenesis. CD36 is a receptor for THROMBOSPONDINS and can act as a scavenger receptor that recognizes and transports oxidized LIPOPROTEINS and FATTY ACIDS.

Antigens, Human Platelet

Human alloantigens expressed only on platelets, specifically on platelet membrane glycoproteins. These platelet-specific antigens are immunogenic and can result in pathological reactions to transfusion therapy.

Gray Platelet Syndrome

A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with THROMBOCYTOPENIA, enlarged platelets, and prolonged bleeding time.

Platelet Storage Pool Deficiency

Disorder characterized by a decrease or lack of platelet dense bodies in which the releasable pool of adenine nucleotides and 5HT are normally stored.

Platelet Glycoprotein Gpib-ix Complex

Platelet membrane glycoprotein complex essential for normal platelet adhesion and clot formation at sites of vascular injury. It is composed of three polypeptides, GPIb alpha, GPIb beta, and GPIX. Glycoprotein Ib functions as a receptor for von Willebrand factor and for thrombin. Congenital deficiency of the GPIb-IX complex results in Bernard-Soulier syndrome. The platelet glycoprotein GPV associates with GPIb-IX and is also absent in Bernard-Soulier syndrome.

PubMed Articles [ 12488 Associated PubMed Articles listed on BioPortfolio]

A randomized trial of platelet transfusions over 30 vs 120 minutes: is there an effect on post-transfusion platelet counts?

Objective:To determine whether platelet infusion time affects platelet counts in thrombocytopenic newborns.Study Design:This was a prospective randomized control study of 43 platelet transfusions give...

Platelet kinetics after slow versus standard transfusions: A pilot study.

Abstract Background. Platelet transfusion is required in the acute phase of some thrombocytopenic disorders in order to prevent potentially dangerous hemorrhages.The purpose of this study was to asses...

Thrombinspondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade.

Cyclic adenosine monophosphate (cAMP)-dependent signalling modulates platelet function at sites of vascular injury. Here we show that thrombospondin-1 (TSP-1) prevents cAMP/PKA signalling through a CD...

Cd36 is important for adipocyte recruitment and affects lipolysis.

OBJECTIVE: The scavenger receptor CD36 facilitates the cellular uptake of long chain fatty acids. Since CD36-deficiency attenuates the development of high fat diet (HFD)-induced obesity, we set out to...

Disseminated Fusariosis and Endogenous Fungal Endophthalmitis in Acute Lymphoblastic Leukemia following platelet transfusion possibly due to Transfusion-Related Immunomodulation.

ABSTRACT: BACKGROUND: To report a case of disseminated fusariosis with endogenous endophthalmitis in a patient with acute lymphoblastic leukemia. Transfusion-associated immune modulation secondary to...

Clinical Trials [ 3476 Associated Clinical Trials listed on BioPortfolio]

A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups

The purpose of this study is to show that a therapeutic platelet transfusion strategy (i.e. platelet transfusion only in case of bleeding) needs minimally a quarter less of transfusions co...

Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus

Plasma histidine-rich glycoprotein (HRG) binds to platelets in the presence of zinc (1). This binding is totally blocked by a monoclonal antibody directed against platelet membrane CD36....

Adult Dengue Platelet Study

Retrospective data in children with dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS), and in adults with dengue fever (DF), suggested a lack of benefit from prophylactic plat...

Strategies for Transfusion of Platelets (SToP)

To evaluate the hemostatic efficacy of a low dose platelet transfusion strategy compared to a standard dose platelet transfusion strategy.

Optimal Platelet Dose Strategy for Management of Thrombocytopenia

The primary objective of this study is to compare the three study arms of lower, medium, and higher dose platelet therapy with respect to the percentage of patients experiencing at least o...

Search BioPortfolio:
Advertisement
Advertisement